Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
4(40%)
Results Posted
0%(0 trials)
Terminated
1(10%)

Phase Distribution

Ph phase_2
1
10%
Ph not_applicable
7
70%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution8 total trials
Phase 2Efficacy & side effects
1(12.5%)
N/ANon-phased studies
7(87.5%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

33.3%

1 of 3 finished

Non-Completion Rate

66.7%

2 ended early

Currently Active

4

trials recruiting

Total Trials

10

all time

Status Distribution
Active(4)
Completed(1)
Terminated(2)
Other(3)

Detailed Status

unknown2
Active, not recruiting2
Recruiting2
Withdrawn1
Completed1
Suspended1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
4
Success Rate
50.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (12.5%)
N/A7 (87.5%)

Trials by Status

unknown220%
withdrawn110%
completed110%
active_not_recruiting220%
suspended110%
terminated110%
recruiting220%

Recent Activity

Clinical Trials (10)

Showing 10 of 10 trials

All 10 trials loaded

Drug Details

Intervention Type
RADIATION
Total Trials
10